OUR TEAM

The right team. The right model.

In a cancer-data landscape marked by big companies, technology giants, and life science companies, Taproot’s focus is on the collection of regulatory-grade data. We have spent 5 years assembling an interdisciplinary team who understands the needs of clinicians, researchers, payers, and regulators. We have built a robust technology platform and unique revenue-sharing model to make it possible.

DANE DICKSON, MD

CEO and Founder

Dr. Dickson is a medical oncologist with deep experience in clinical trial reporting, molecular medicine, and data collection.

REBECCA OWENS

President and Co-Founder

Rebecca Owens is a healthcare executive who has worked to advance precision medicine over the past 20 years.

RAZELLE KURZROCK, M.D.

Principal Investigator and Scientific Advisor

Chief, Division of Hematology & Oncology | Director, Center for Personalized Cancer Therapy & Clinical Trials Office | Senior Deputy Director, Clinical Science | Moores Cancer Center, University of California at San Diego.

RAYMOND BERGAN, M.D.

Principal Investigator and Scientific Advisor

Chief, Division of Hematology & Medical Oncology, Associate Director, Knight Cancer Institute.

JENNIFER JOHNSON, M.D., PHD

Principal Investigator and Scientific Advisor

Assistant Professor, Department of Medical Oncology, Thomas Jefferson

VIVEK SUBBIAH, M.D.

Principal Investigator and Scientific Advisor

Associate Professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX.